Work

Open-label riluzole in fragile X syndrome

Year: 2010

Type: article

Study design: Clinical Trial

Source: Brain Research

DOI: 10.1016/j.brainres.2010.10.108

Authors: Craig A. Erickson, Ning Weng, Ivan Jeanne Weiler, William T. Greenough, Kimberly A. Stigler, Logan K. Wink, Christopher J. McDougle

Institutions: Indiana University Hospital, Riley Hospital for Children, Christian Sarkine Autism Treatment Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, University of Illinois Urbana-Champaign

Language: English

Topic: Genetics and Neurodevelopmental Disorders

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute of Mental Health, National Center for Research Resources

Awards: Targeted Pharmacologic Interventions for Autism, G4854094273, Indiana Clinical and Translational Science Institute (UL1), Novel Pharmacological Strategies in Autism, 1/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD, Pharmacotherapy of Pervasive Developmental Disorders

OpenAlex ID: W2000853219

FWCI: 3.155

Cites: 48

Cited by: 65

Related to: 10